Bradykinesia in Huntington's disease

P J Garcia Ruiz1, E Gomez Tortosa, V Sanchez Bernados

  • 1Department of Neurology, Fundacion Jimenez Diaz, Madrid, Spain.

Clinical Neuropharmacology
|February 22, 2000
PubMed

Insights

Huntington's disease (HD) patients exhibit significant bradykinesia, performing worse than healthy controls and even Parkinson's disease patients on motor tasks. Motor impairment in HD correlates with disease severity.

Area of Science:

  • Neurology
  • Movement Disorders

Background:

  • Huntington's disease (HD) is primarily known for hyperkinetic movements.
  • However, bradykinesia (slowness of movement) is also a common feature in HD patients.
  • Understanding the motor deficits in HD is crucial for diagnosis and management.

Purpose of the Study:

  • To compare the motor performance of Huntington's disease patients with healthy controls and Parkinson's disease patients.
  • To investigate the presence and severity of bradykinesia in HD.
  • To determine the relationship between motor impairment and clinical stage in HD.

Main Methods:

  • Evaluated motor performance in 18 genetically confirmed HD patients, 18 controls, and 20 Parkinson's disease (PD) patients.
  • Utilized four standard PD timed motor tests: Pronation-Supination (PS), Finger Dexterity (FD), Movement Between Two Points (MTP), and Walking Test (WT).
  • HD and PD groups were assessed under specific conditions (HD off neuroleptics, PD off medication).

Main Results:

  • HD patients were significantly slower than controls across all motor tasks (p < 0.01).
  • HD patients demonstrated slower performance than PD patients in finger dexterity (p < 0.05).
  • All motor tests showed a significant positive correlation with the clinical stage of HD (r values ranging from 0.75 to 0.87).

Conclusions:

  • Severe bradykinesia is a significant motor impairment in Huntington's disease.
  • Motor deficits in HD are directly related to the clinical stage of the disease.
  • HD patients exhibit profound motor slowing, comparable to or exceeding that seen in Parkinson's disease for certain tasks.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...